Early events in the biosynthesis of liver catalase were studied on female rats receiving intermediates, the first lacking heme and representing about 1 .6% of the total catalase content or 13 µg/g liver, the second containing heme and representing about 0 .5 1, 10 of the
INTRODUCTION
It is widely assumed that peroxisomes arise in rat liver in the form of projections budding off from the endoplasmic reticulum . Experiments designed to explore some of the biochemical implications of this model have, however, failed so far to provide any support for it (17, 18) . The model has not been entirely ruled out, but its possible time scale has been considerably restricted . According to available results, if peroxisomes do grow as buds off the endoplasmic reticulum, then they must reach their final size in considerably less than 3 h, and probably in even less than 1 h or 2 % of their average life-span . An alternative possibility is that the peroxisomes do not exist as independent individuals in the intact cells, but are interconnected, THE JOURNAL OF CELL BIOLOGY . VOLUME 59, 1973 • pages 4 9 1 -506 either permanently or intermittently, in such a way as to continually interchange their contents .
In the present studies, we have looked at the early events whereby rat liver catalase is synthesized and deposited within peroxisomes . We used radioactive tracers to label catalase, immunochemical methods to separate catalase from other liver proteins, and density gradient centrifugation to fractionate the cells . In this paper we report on the kinetics of catalase biosynthesis, which takes place by way of at least two distinct biosynthetic intermediates . In the subsequent paper we describe the cell fractionation experiments, which show the intracellular pathway followed by the intermediates (10) . The results presented here form part of the Ph .D . thesis of one of us (Lazarow [8] ) and have been reported in preliminary communications (7, 9) .
MATERIALS AND METHODS

Materials
Rats were obtained from Charles River Breeding Laboratories, Inc. (Wilmington, Mass.) .
Labeled compounds were purchased from Schwarz/ Mann (Orangeburg, N . Y.) in 0 .01 N HCI . They were neutralized and adjusted to isotonicity by the addition of 0.1 vol of 0.55 M NaHCO3 in 1 .14 M NaCl .
All chemicals were of reagent grade . Bovine serum albumin (BSA)' was obtained as bovine plasma fraction V from Armour Pharmaceutical Co . (Kankakee, Ill .) . Horse heart cytochrome c, bovine pancreatic trypsin, chicken ovalbumin, and bovine liver catalase were purchased from Sigma Chemical Co . (St. Louis, Mo .) .
Biochemical Assays
Catalase activity was determined by the method of Baudhuin et al . (2) . One unit of activity decreases the H202 concentration 10-fold per minute in a reaction volume of 50 ml at 0°C. Protein was measured by the automated Lowry technique of Leighton et al . (11) , and is expressed in milligrams based on a BSA standard .
Radioactivity Determinations
Total proteins were precipitated with cold 10% trichloroacetic acid (TCA) containing 1 mM leucine and 0 .5 mM 8-aminolevulinic acid (ALA) . The precipitates were collected by centrifugation and washed 3 times with cold 5% TCA, containing 1 mM leucine and 0.5 mM ALA . Catalase antigen was recovered by immunoprecipitation, as described below . The precipitated proteins were dissolved in 0 .1 N NaOH and a 0.5 ml sample was mixed with 10 ml of Triton-toluene scintillation fluid (9) followed by 10 ,ttl of glacial acetic acid . Radioactivity was determined in a Packard no . 3375 scintillation counter equipped with no . 7400056 bialkali phototubes ' Abbreviations used in this paper : ALA, 3-aminolevulinic acid ; BSA, bovine serum albumin ; DAB, 3,3'-diaminobenzidine ; ML, mitochondrial plus light mitochondrial fraction (2) ; PBS, phosphate-buffered saline, 0.15 M NaCl + 10 mM phosphate buffer, pH 7.0 ; PBSLA, PBS containing 0 .1 MM L-leucine and 0 .01 mM ALA ; PCI, purified catalase immunoprecipitate ; SDS, sodium dodecyl sulfate ; TCA, trichloroacetic acid ; WLI, whole liver immunoprecipitate . 4 
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Immunological Assays
The titer and specificity of anticatalase preparations were assessed by conventional quantitative immunoprecipitation and Ouchterlony double diffusion (using immunodiffusion cells containing reservoirs of antigens and antibody, Cordis Laboratories, Miami, Fla.), and by a semiquantitative microimmunodiffusion assay which was developed to monitor the purification of anticatalase .
Purification of Catalase
The anticatalase preparations used in previous work contained antibodies against liver constituents other than catalase, making it necessary to partly purify catalase before immunoprecipitation (17) . We wished to eliminate this requirement and set out to improve the purification of rat liver catalase (12) . Substituting purified peroxisomes (11) for the crude mitochondrial plus light mitochondrial (ML) fraction used previously as starting material raised the specific activity of the purified enzyme by 15% (Table I) . The material isolated in this manner behaved as a homogeneous protein of molecular weight about 240,000 on Sephadex G-200 chromatography and migrated in the form of homogeneous subunits of molecular weight 60,000 on sodium dodecyl sulfate-(SDS)-polyacrylamide gel electrophoresis, indicating that only contaminants having the same molecular size and tetrameric structure as catalase could have been present in significant quantities . As will be shown below, such contaminants, if present, did not induce the formation of detectable amounts of antibodies . Despite these evidences of purity, our new preparations attain only 80% of the specific activity of those described by Price et al . (19) . Possible reasons for this discrepancy have been discussed before (12) .
Preparation of Anticatalase
The purified catalase was used for the purification of anticatalase from an impure rabbit antiserum, and for the production of a monospecific goat antiserum .
The anticatalase was purified by the following modification of the solid-phase immunoadsorbent technique of Avrameas and Ternynck (1) : 300 mg of BSA were first polymerized by means of 0 .7% glutaraldehyde in 0 .2 M acetate buffer, pH 5 .0 . The resulting gel was homogenized into small pieces and washed. Then 4.8 mg of purified rat liver catalase were attached to the BSA gel by means of 0 .2% glutaraldehyde . The gel was washed once and treated with several changes of 100 mM ethanolamine to block free glutaraldehyde ends . All the above operations were carried out in 0 .2 M acetate buffer, pH 5 .0 . Finally the gel was thoroughly washed with, and resuspended in, 0 .15 M NaCl buffered to pH 7 with 10 mM phosphate (PBS) . To this suspension were added 20 ml of rabbit antiserum, containing an amount of anticatalase (about 13 mg, see below) approximately equivalent to the catalase on the gel, in 1 .4 g of total protein . The gel was thoroughly washed with PBS and about 50% of the anticatalase and more than 1 .3 g of protein appeared in the washes . Therefore, the gel-bound catalase retained about 1 .4 times its weight of anticatalase, a value which compares favorably with the ratios of 0.2-1 .0 reported by Avrameas and Ternynck (1) . Anticatalase was eluted from the gel with several changes of 0 .1 M glycine-HCI buffer pH 2.8 . The eluates were passed through a 0 .22 ttm Millipore filter, and dialyzed against PBS . About 80% of the adsorbed anticatalase was recovered in this manner . The gel was reused twice after thorough rinsing in PBS ; there was some loss in anticatalase binding capacity with repeated use . The three batches of purified anticatalase were pooled and characterized by quantitative immunoprecipitation and by immunodiffusion . As shown in Fig. 1 , 300 µl of purified anticatalase are equivalent to about 0.9 U (15 µg) of catalase . In the equivalence zone, the precipitate contains about 58 µg of protein, which corresponds to a molar ratio of -y-globulin to catalase of 4.4 (assuming a molecular weight of 150,000 for the rabbit -y-globulins) . This is a reasonable value for a protein of the size of catalase (6) . The 300 µµ1 of purified anticatalase contained 118 µg of protein . Of this, a maximum of 43 µg precipitated, indicating that the anticatalase was 36% pure, and therefore had been purified about 40-fold over the original serum. Immunodiffusion revealed no antibody other than anticatalase in the purified preparation . The antibody solution was sterilized by filtration through a 0.22 µm Millipore membrane and stored in the cold room. Its potency remained unchanged for at least 6 mo.
The second antibody preparation was raised in a goat with 7 mg of pure catalase . The animal was bled 2 mo after immunization, and a number of times thereafter. Globulins were precipitated from the serum by half saturated (NH4)2SO4, washed, resuspended in an amount of 0 .15 M NaCl equal to half the original volume of serum, dialyzed extensively against 0 .15 M NaCl, sterilized by Millipore filtration, and frozen in small lots . Control globulins were similarly prepared from serum obtained from the goat before immunization.
The anticatalase titer in the globulin preparation, determined by quantitative immunoprecipitation, was 1 .2 ml of globulins (2 .4 ml of serum) equivalent to 60 U of catalase. This is twice as much anticatalase per milliliter of serum as we obtained in rabbits, despite the fact that the rabbits received about 10 times more antigen per unit body weight than did the goat .
The specificity of the goat antiserum was determined by immunodiffusion against purified catalase and rat liver postnuclear supernate (Fig . 2) . The relative concentrations of the reactants were varied more than 100-fold (ranging from great antibody excess to great antigen excess) without revealing any immunoprecipitate other than that formed by catalase and anticatalase . This precipitate caused the evolution of 02 bubbles when flooded with H202, and stained with the 3 , 3'-diaminobenzidine (DAB) reaction of Graham and Karnovsky (3) as modified by Novikoff and Goldfischer (15) . When the andcatalase was replaced by control goat globulins, no immunoprecipitate could be detected . Immunoelectrophoresis also failed to reveal any contaminating antibody-antigen system .
Immunoprecipitation of Catalase
The immunoprecipitation technique used in earlier work was adapted to the separation of labeled catalase from crude liver fractions solubilized by 1 % Triton X-100 . Serious difficulties were encountered due to nonspecific precipitation, especially with certain mitochondrial fractions. The main factor responsible for this phenomenon was found to be protein denaturation during the 1 h incubation at 37°C. We were able to avoid this artifact to some extent by adding soluble proteins (4 mg/ml rabbit serum globulins) to the system, and more effectively by performing the immunoprecipitation entirely at 0°C, as recommended by Higashi and Kudo (5) . Adsorption to glass was another source of nonspecific contamination, which was prevented by siliconizing the tubes . On the other hand, contrary to the experience of some other workers, adsorption to the immunoprecipitate itself was of minor importance in our work, and a preliminary immunoprecipitation of an added antigen (ovalbumin) did not significantly reduce contamination . c As a result of these and other trials, the following procedure was finally adopted . Frozen homogenates or subcellular fractions were thawed and treated with Triton X-100 to a final concentration of 1% . They were then diluted with an appropriate solute mixture to the following final concentrations (PBSLA) :NaCl, 0 .15 M ; potassium phosphate buffer, pH 7 .0, 10 mM ; L-leucine, 0 .1 mM ; ALA, 0 .01 mM ; sucrose, <0.4 M ; Triton X-100, <0 .4% ; and catalase, <0 .8 U/ml . The samples were passed under positive pressure through 0.22 µm Millipore filters . Catalase activity and radioactive proteins were quantitatively recovered in the filtrates . 2 .5 ml of the filtered solutions were pipetted into tared, siliconized, conical, 5-ml glass centrifuge tubes, and incubated overnight at 0°C with an amount of anticatalase equivalent to 2 .5 U of catalase . A second 2.5 ml aliquot was treated identically, but with control globulins. The precipitates were collected by centrifugation for 1 h at 2,000 rpm in swing-out buckets in a refrigerated International centrifuge (International Scientific Instruments Inc ., Palo Alto, Calif.), washed twice with 2 .5 ml of PBSLA, and dissolved by addition of 0 .5 ml of 0 .1 N NaOH . The tubes were weighed to provide a measurement of the total volume of the resulting solution, and a 0.5 ml sample was taken for scintillation counting. The radioactivity found in the control tubes was subtracted from that recovered with anticatalase . This correction varied between 5 and 35%, depending on the precursor and the labeling time . As a check of the overall reliability of the procedure, catalase activity was assayed systematically in the original samples and in the supernates from the im-FIGURE 2 Immunodiffusion of goat anticatalase vs . rat liver extract (postnuclear supernate) and purified catalase . The undiluted extract contains 0 .2 g liver/ml, the undiluted catalase contains 11 U/ml, and the undiluted anticatalase is the goat globulin preparation described in the text . Immunodiffusion was for 6 days at 0°C . The unstained precipitates were photographed by scattered light (23) .
munoprecipitations . In all cases, less than 1 % of the activity remained in the supernate after immunoprecipitation, as compared with 80-100% in the control supernates . Therefore the immunoprecipitations were essentially complete. Anticatalase has little effect on the activity of the enzyme, and when immunoprecipitation is not complete, catalase activity is found in the supernate (Fig. 1, open circles) .
Micropurification and Immunoprecipitation of Catalase
Immunoprecipitation was carried out also after a preliminary purification of catalase, which was performed as follows : At 0°C, a 1 .5 ml sample was shaken vigorously with 7 ml of 27% ethanol in 54 mM acetate buffer, pH 4 .1, and 0.5 ml of chloroform . After centrifugation for 1 min at 1,500 rpm, the lower chloroform phase was removed with a Pasteur pipette, 0.1 ml of 0 .5 M Na2SO4 was added and the tube was shaken again . The resulting precipitate was collected by centrifugation for 15 min at 40,000 rpm, extracted overnight with 2 ml of 10 mM potassium phosphate buffer, pH 7 .0, and recentrifuged for 30 min at 40,000 rpm . The supernate contained 50-70% of the catalase activity with 3-4% of the total protein and 5-15% of the total TCA-precipitable radioactivity (after leucine labeling) . It was used for immunoprecipitation as described above, except that the Millipore filtration step was omitted. The radioactivity measured in the immunoprecipitate was corrected for the observed loss in catalase enzymatic activity upon purification . • mogenized in 0 .25 M sucrose containing 0 . 1 0/ . ethanol (to protect the catalase activity) . The homogenates were assayed for catalase and protein, and for TCAprecipitable and immunoprecipitable radioactivities, as described above . In all cases, immunoprecipitates were separated without, as well as after, partial purification of catalase . The former, termed whole liver immunoprecipitate (WLI), contained all the material that was recognized by anticatalase antibodies (including at least 99% of the catalase enzymatic activity) . The latter, designated purified catalase immunoprecipitate (PCI), contained only catalase antigen that As shown in Fig . 4 (solid circles), incorporation of leucine into the WLI paralleled closely its incorporation into TCA-insoluble material . The plateau value is of the order of 0 .0055 % of the injected dose per gram liver, or 0 .45 % of the amount incorporated into TCA-precipitable material . The appearance of labeled leucine in the PCI followed a very different course (Fig . 4, open circles) . There is a suggestion of a lag of 2-3 min, followed by a slow and gradual increase, up to a value which at the end of 2 h reaches 80% of that found in the WLI .
With [3H]ALA as precursor (Fig . 5 , solid circles) incorporation of label into the WLI occurred much more slowly than it did into TCA-insoluble material, being far from completed even after 2 h . The uptake of label into the PCI (Fig . 5 , open circles) was even slower, so that a distinct difference between the radioactivities of the two immunoprecipitates, qualitatively similar to that recorded after injection of [ 3H]leucine, was observed . Except for a single value, at 120 min, the proportion of total immunoprecipitable label recovered in the PCI was always larger with ALA than with leucine as precursor (Table II) .
Later time points were investigated on unanesthetized animals receiving the labeled precursors by intraperitoneal injection . As shown in Table  III , after 3 h the PCI contained only 70-80% of the radioactivities present in the WLI . By 18 h the difference had completely disappeared . Fig . 6 shows the result of an SDS-gel electrophoretic analysis performed on the material recovered in the WLI 8 min after intraportal injection of [3H]leucine . The larger part of the label migrated essentially like catalase itself . The balance presumably corresponds to the 29 % of nonspecific label found in the control tube .
Double-Labeling Experiments
In the fractionation experiments reported in the following paper (10) Values are means f standard error of the mean . The number of experiments is given in parentheses .
amounts were substantially higher in terms of micromoles than those used in the single-labeling experiments, especially for ALA, where the dosage was increased between 200-and 1,000-fold in the double-labeling experiments (see 10) . The leucine incorporation results fell well within the range observed in the single-labeling experiments, as can be seen in Figs . 3 and 4 , where they are represented by triangles . However, close inspection of the results reveals what may possibly be a significant difference between the two sets of data . It will be noted that leucine incorporation in the double-labeling experiments tends to be high 49 8 THE JOURNAL OF CELL BIOLOGY • VOLUME 59, 1973 in the TCA precipitate (Fig . 3) and low in the WLI (Fig. 4) , so that the actual ratio of labeled catalase to total labeled proteins is substantially lower in the double-than in the single-labeling experiments .
The incorporation kinetics of ALA were greatly affected by the change in precursor dosage (Fig .  7) . There was a marked lag in the incorporation of ALA into TCA-insoluble material, without, however, any apparent decrease of the plateau value . Incorporation of ALA into the WLI showed an even greater lag. As in the single-labeling experiments the fraction of WLI label found in the PCI Slice number FIGURE 6 SDS-polyacrylamide gel electrophoresis of WLI isolated 8 min after injection of [ 3 H]leucine . The sample was heated to 100°C for 5 min in the presence of 1% SDS and 0 .1 0 /0 (3-mercaptoethanol, electrophoresed in the SDS-phosphate system of Maizel (14) on a 4% polyacrylamide gel, and stained with Coomassie blue . After staining, the gel was sliced and the radioactivity in each slice determined (13) . The position and width of the stained catalase band in this gel is indicated . The nonspecific radioactivity in the immunoprecipitate (control tube) was 29% of the total, presumably accounting for the minor peaks .
was larger with ALA than with leucine as precursor (Table II) .
DISCUSSION
General Features
INCORPORATION OF LEUCINE : Afterintraportal injection of [3H]leucine, label incorporated into TCA-precipitable material as well as into the WLI rises . rapidly to a plateau which seems to remain unchanged for at least 2 h . The shape of these curves indicates that thanks to the intraportal route of injection, the specific radioactivity of the liver free leucine pool fell rapidly .
Labeled leucine enters the PCI much more slowly and progressively than it does the WLI .
The difference between the radioactivities of the two immunoprecipitates belongs to material that accompanies catalase upon immunoprecipitation, but not through purification . As label leaves this material, an equal amount becomes associated with purifiable catalase antigen . Most of this transfer takes place at a time when incorporation of labeled leucine into total protein and into the WLI has ceased . These properties clearly identify the material as playing an intermediate role in the biosynthesis of catalase . The nature of this material will be discussed below .
Essentially the same results were obtained in the single-and in the double-labeling experiments, except for a hint that in the latter experiments the synthesis of catalase may have been inhibited, or The incorporation of [3H]ALA into TCA-insoluble material follows a course very similar to that of leucine incorporation, indicating that ALA is rapidly converted to TCA-precipitable heme or heme precursors, by way of one or more TCA-soluble intermediate pools that must all be of small size . Label entered the WLI throughout the 2 h experiment, indicating the existence between ALA and catalase-bound heme of at least one TCA-insoluble pool with a relatively long half-life and large size, most probably free heme, but possibly a reservoir of bound but rapidly exchangeable heme .
In the double-labeling experiments, where [3H]ALA was replaced by [14C]ALA, the incorporation kinetics were very different, being characterized by considerable lags . As will be shown more conclusively below, this difference is almost certainly due to pool inflation by the large amounts of ALA that were given in these double-labeling experiments . The resulting disturbance of the steadystate conditions may also have affected some aspect of catalase or protein synthesis, as mentioned above .
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THE (Table II) , with the exception of a single point at 120 min, the percentage of total labeled antigen (WLI) which was converted into purifiable catalase (PCI) was always larger with ALA than with leucine as precursor . This was true in the very same rats, in the double-labeling experiments, as well as in separate groups of rats . This result might be reconciled with a single-intermediate model only if the radioactivity of the leucine pool could be shown to decay more slowly than that of the heme pool since in this case proportionately more label would continue to enter the intermediate pool from leucine than from ALA . In fact we find exactly the opposite . Therefore the single-intermediate model must be rejected . There must be at least two biosynthetic intermediates of catalase that are precipitated by anticatalase, but do not survive purification . Both contain leucine, but only the second one contains heme . This model is illustrated in Fig. 8 .
We know from the SDS-gel electrophoresis (Fig .  6 ) that the leucine-labeled material, which includes the two intermediates, has a monomeric molecular weight of 60,000 equal to that of catalase . Native catalase has a molecular weight of 240,000 and is believed to consist of four identical subunits (21, 22) . As we will see in the following paper (10), the leucine-labeled material sediments in 0.25 M sucrose at the same rate as hemoglobin, and much more slowly than catalase itself, indicating that this labeled material is a monomer of molecular weight 60,000 . Under the conditions of these experiments (8 min labeling time) approximately 89 % of the label is in the first intermediate and only 9 % in the second (see below, Eqs . 9 and 10) . Therefore we can conclude that the first biosynthetic intermediate is an aposubunit, but we cannot be sure of the molecular weight of the second . The simplest hypothesis is that it is a subunit, but other possibilities can be envisaged .
Kinetic Analysis
METHOD : The model of Fig . 8 can be represented by a well-known set of equations (see Appendix) . We have attempted to fit our results to these equations, both to test the validity of the model, and, in case of a satisfactory fit, to estimate the turnover times, and thereby the pool sizes, of the biosynthetic intermediates . Fitting was done by computer by a trial and error method, using a least squares criterion of goodness of fit . The results of this analysis are summarized in Table IV . PRECURSOR POOLS : The turnover time of the leucine pool, T L , is estimated from the incorporation curves of leucine into total TCA-precipitable material (Fig . 3 A) and into the WLI (Fig . 4 , Eq . 12) . Both curves yield almost identical estimates of TL , of the order of 2 .5 min, with plateau values of L t = 1 .2% of the injected dose per gram liver for the total leucine incorporation into TCA-precipitable material, and LI = 0 .0055% of the injected dose per gram liver for its incorporation into the WLI .
Inserting the values of TL and L1 , and the known rate of catalase synthesis k (about 0 .12 nmol of leucine/g liver per min in our animals) into Eq . 17, we estimate the initial specific radioactivity of the free leucine pool, L o /1, to be of the order of 0 .018% of the injected dose per nanomole of leucine . From this value, in turn, we derive the leucine pool size limits given in Table IV, An additional conclusion we can derive from these calculations is that the amounts of leucine injected (less than 100 nmol/g liver in all cases) did not significantly increase the size of the leucine pool (less than 1 .8%) .
Our estimates of the kinetic constants of the heme pool are more imprecise because the turnover time of this pool is too slow relative to the time scale of our experiments so that incorporation of [3H]ALA into the WLI has not yet reached a plateau . As illustrated in Fig . 5 , a fairly good fit with Eq . 16 is obtained with TI, = 170 min and HI = 0.104% of the injected dose per gram liver .
Less uncertainty affects the ratio HI/TH , which, entered into Eq . 18 together with the rate of catalase synthesis k' (about 4 .4 pmol of heme/min per g liver in our animals), yields an estimate of the initial specific radioactivity of the heme pool, Ho/h, equal to 0 .14% of the injected dose per nanomole of the heme . This corresponds to a maximum pool expansion of 0 .025% when [ 3H]-ALA was' given, since we injected about 11 nmol of ALA, the equivalent of 0 .18 nmol of heme/g liver. With [14C]ALA, however, the dosage was 200-to 1,000-fold greater, so that the total amount of ALA added was equivalent to between 5 and 25% of the heme pool . Expansion of the small preceding pools of ALA and other acid-soluble intermediates must have been much greater, and the considerable lag observed in the uptake of [14C]-ALA, as compared to the tritiated precursor (Fig .  7) , is thereby explained .
To estimate the limits of h, the heme pool size, we have assumed that all the labeled heme, free or bound, of the liver is recovered into the TCA precipitate. Then H., the extrapolated initial radioactivity in the heme pool, cannot be larger than 1 .5' of the dose per gram liver, the plateau value of the incorporation curve of [ 3H]ALA into TCAprecipitable material (Fig . 3 B) , nor smaller than 0 .104% of the dose per gram liver, the estimated plateau, H1 , of the incorporation curve of [ 3H]-ALA into the WLI (Fig . 5) . Inserting these two limits of Ho into the estimated Ho/h ratio, we find 502 THE JOURNAL OF CELL BIOLOGY . VOLUME 59, 1.973 that h must lie between 0 .7 and 10 nmol of heme/g liver (Table IV) .
INCORPORATION OF ALA : The results of Fig . 5 were used to estimate TQ , the turnover time of the heme-containing Q intermediate (Fig . 8) . For this purpose the radioactivities of the PCI (C) were expressed as fractions of the radioactivities of the WLI (Q' + C') and the ratio of Eqs . 15 and 16 fitted to them, using T H = 170 min as estimated above . The best fit was obtained with T Q = 17 min (Fig. 9) . The goodness of fit of Eq . 15 to the unnormalized experimental data may be seen in Fig . 5 . Since the turnover time of catalase is of the order of 3,100 min (16, 18, 19) , the hemecontaining intermediate represents a little more than 0.5 % of the total catalase, or about 4 µg/g liver . INCORPORATION OF LEUCINE : The leucine results (Fig . 4) were similarly normalized and the ratio of Eqs . 11 and 12 fitted to them using TL = 2 .5 min and TQ = 17 min (Fig. 10) . The best value for TI was 49 min, corresponding to an amount of intermediate, I, equal to 1 .6% of the total hepatic catalase content, or 13 µg/g liver . The goodness of fit of Eq . 11 to the unnormalized experimental data may be seen in Fig . 4 .
The fits2 are not very satisfactory, mainly because our data show little evidence of the initial lag foreseen by the theory . Such a lag is mandatory in any two-intermediate model, unless both intermediates have very short turnover times . But in the latter event the plateau would be approached much more rapidly than it is found to be . The simplest explanation that could account for the discrepancy is that the PCIs are slightly contaminated by a radioactive impurity or that a small proportion of the intermediates survives purification . Or, it could be that the pool sizes and turnover times vary greatly in different parts of the tissue or of the cells, resulting in a composite curve depicting a combination of early and of late labeling . Alternatively, if some of the apomonomer aggregated directly to a hypothetical purifiable apotetramer, the absence of a lag would be readily understood .
CONCLUSIONS : Our interpretation of the data is summarized in Fig . 11 . Catalase biosynthesis proceeds by way of at least two intermediates . The first is an aposubunit of molecular weight 60,000 . It has a turnover time of 49 min and constitutes 1 .6% of the total cell catalase . The second intermediate contains heme, has a turnover time of 17 min, and constitutes 0 .5% of the cell catalase . The simplest hypothetical structure for it compatible with our data is that of a subunit ; however, the detailed relationship between aggregation and heme addition is unknown . The fit of the theoreti- 
Technical Comments
The selectivity of immunoprecipitation as applied to a complex mixture like a liver homogenate, is limited by two factors : the purity of the reagents and the nonspecific precipitation that inevitably occurs . These problems are all the more serious in short-term labeling experiments such as these when a minor protein with a long half-life is precipitated ; a rapidly turning over impurity can add significantly to the radioactivity of the immunoprecipitate . Catalase, whose synthesis represents only 0 .45% of the total protein synthesis, is quite unfavorable in this respect .
After extensive trials, we found conditions where nonspecific precipitation was very low . The residual contamination was estimated with control serum, as explained under Materials and Methods . The following facts show that the procedures used were adequate for our purpose and free of serious artifacts : Radioactivity in the W LI reached a stable plateau (indicating the absence of rapidly turning over or secreted impurities) . The radioactivities in 
in which, L, I, Q, C, are the total radioactivities from leucine, H', Q', and C', the total radioactivities from ALA, in the corresponding pools (per gram liver) ; the T's are the turnover times of the pools' ; k and k' are the rates of synthesis of catalase in nanomoles per minute per gram liver, of leucine and heme, respectively ; I and h are the respective pool sizes of leucine and heme in nanomoles per gram liver. Two simplifications have been introduced in these equations : the decay of catalase, which is less than 4 % in 2 h, has been neglected in Eqs . 4 and 7 ; participation of ALA and of the intermediates between ALA and heme has been neglected in Eq . 5 . By heme pool is meant the pool from which label administered as ALA enters the Q intermediate .
The solutions to this set of differential equations are the following : 
Inspection of Eqs. 12 and 16 indicates that LI and HI are the total leucine and heme radioactivities that will ultimately be incorporated into catalase .
Operationally, C and C' are the radioactivities in the PCI, whereas I + Q + C and Q' + C' are the radioactivities in the WLI . 
